Pharmaceutical compositions
A liquid pharmaceutical composition providing improved oral bioavailability is disclosed for compounds which are inhibitors of HIV protease. In particular, the composition comprises a solution in a pharmaceutically acceptable organic solvent of (a) the HIV protease inhibitor and optionally, (b) a su...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
04.07.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A liquid pharmaceutical composition providing improved oral bioavailability is disclosed for compounds which are inhibitors of HIV protease. In particular, the composition comprises a solution in a pharmaceutically acceptable organic solvent of (a) the HIV protease inhibitor and optionally, (b) a surfactant. The composition can optionally be encapsulated in either hard gelating capsules or soft elastic capsules (SEC). |
---|---|
Bibliography: | Application Number: CN200510128757 |